H1N1 Vaccine Production Plodding, But 49.9 Million Doses Available

Travis Martinez, University of New Mexico-Talk Radio News Service

Anne Schuchat, Director of the Center for Disease Control and Prevention’s National Center for Immunization and Respiratory Diseases acknowledged the slow production of H1N1 vaccines, but says there are nearly 50 million doses available to the States for use.

“Like everyone, I’m disappointed in the initial production,” said Schuchat during a hearing with the House Energy and Commerce Committee. “However, today we can announce there are 49.9 million doses available of H1N1 vaccine for the states to order.”

“Its not as much as we wanted to have by now, or, frankly what we needed to have by now, but every dose is being rapidly moved out,” Schuchat added.

Chairman Henry Waxman (D-Calif.) praised the initial response to the virus, but also recognized the dangers posed by the vaccine shortage.

“The hope was that a robust vaccine supply would arrive before infections began to soar and everyone worked as quickly as possible to meet that goal. These hopes were not met. The past several weeks have reminded us that the process of making flu vaccines is unpredictable and challenging,” said Waxman.

Assistant Secretary for Preparedness and Response Nicole Lurie was grilled by Rep. Greg Walden (R-Oregon), who was diagnosed in late October with H1N1.

“We had testimony September 15 from Secretary Sebelius and everything seemed to be on track and fine. So, explain who, did the manufacturers, weren’t they straight with you?” asked Walden.

“There’s nobody to blame here, there’s no smoking gun,” Lurie said.

CDC estimates nearly 22 million Americans have been infected with H1N1. Of the 22 million infected, 98,000 were hospitalized and nearly 4,000 have dead.